Development of the Japanese version of the 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (J-IQCODE 16) for the Diagnosis of Prestroke Dementia
The 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE 16) has been frequently used to diagnose prestroke dementia, an important determinant of stroke prognosis. We developed the Japanese version of the IQCODE 16 (J-IQCODE 16) using standardized translation methods. We applied the J-IQCODE 16 to 102 patients with stroke (19 with prestroke dementia diagnosed with DSM-5) admitted to the stroke care unit in our hospital. The cohort was randomly divided into a derivation cohort and a validation cohort containing 51 patients each. In the derivation cohort, the median J-IQCODE 16 score was 3.06, and the area under the receiver operating characteristic curve for prestroke dementia was 0.96, with an optimal cutoff value of 3.25 determined using the Youden index. When applied this cut-point to the validation cohort, the sensitivity and specificity of the J-IQCODE 16 for prestroke dementia were 90% and 85%, respectively. The J-IQCODE 16 is considered useful for the diagnosis of prestroke dementia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
---|---|
Enthalten in: |
Rinsho shinkeigaku = Clinical neurology - 63(2023), 5 vom: 27. Mai, Seite 275-285 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Egashira, Shuhei [VerfasserIn] |
---|
Links: |
---|
Themen: |
English Abstract |
---|
Anmerkungen: |
Date Completed 30.05.2023 Date Revised 30.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.5692/clinicalneurol.cn-001834 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356042421 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356042421 | ||
003 | DE-627 | ||
005 | 20231226065623.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||jpn c | ||
024 | 7 | |a 10.5692/clinicalneurol.cn-001834 |2 doi | |
028 | 5 | 2 | |a pubmed24n1186.xml |
035 | |a (DE-627)NLM356042421 | ||
035 | |a (NLM)37100621 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Egashira, Shuhei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development of the Japanese version of the 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (J-IQCODE 16) for the Diagnosis of Prestroke Dementia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.05.2023 | ||
500 | |a Date Revised 30.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE 16) has been frequently used to diagnose prestroke dementia, an important determinant of stroke prognosis. We developed the Japanese version of the IQCODE 16 (J-IQCODE 16) using standardized translation methods. We applied the J-IQCODE 16 to 102 patients with stroke (19 with prestroke dementia diagnosed with DSM-5) admitted to the stroke care unit in our hospital. The cohort was randomly divided into a derivation cohort and a validation cohort containing 51 patients each. In the derivation cohort, the median J-IQCODE 16 score was 3.06, and the area under the receiver operating characteristic curve for prestroke dementia was 0.96, with an optimal cutoff value of 3.25 determined using the Youden index. When applied this cut-point to the validation cohort, the sensitivity and specificity of the J-IQCODE 16 for prestroke dementia were 90% and 85%, respectively. The J-IQCODE 16 is considered useful for the diagnosis of prestroke dementia | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE) | |
650 | 4 | |a prestroke dementia | |
650 | 4 | |a self-administered questionnaire | |
650 | 4 | |a translation | |
650 | 4 | |a validation | |
700 | 1 | |a Tanaka, Kanta |e verfasserin |4 aut | |
700 | 1 | |a Oka, Azusa |e verfasserin |4 aut | |
700 | 1 | |a Nagasawa, Yoko |e verfasserin |4 aut | |
700 | 1 | |a Kohama, Kaoru |e verfasserin |4 aut | |
700 | 1 | |a Tokunaga, Azusa |e verfasserin |4 aut | |
700 | 1 | |a Ohata, Akiko |e verfasserin |4 aut | |
700 | 1 | |a Kakuta, Chikage |e verfasserin |4 aut | |
700 | 1 | |a Funabiki, Yasuko |e verfasserin |4 aut | |
700 | 1 | |a Toyoda, Kazunori |e verfasserin |4 aut | |
700 | 1 | |a Ihara, Masafumi |e verfasserin |4 aut | |
700 | 1 | |a Koga, Masatoshi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rinsho shinkeigaku = Clinical neurology |d 1972 |g 63(2023), 5 vom: 27. Mai, Seite 275-285 |w (DE-627)NLM000226874 |x 1882-0654 |7 nnns |
773 | 1 | 8 | |g volume:63 |g year:2023 |g number:5 |g day:27 |g month:05 |g pages:275-285 |
856 | 4 | 0 | |u http://dx.doi.org/10.5692/clinicalneurol.cn-001834 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 63 |j 2023 |e 5 |b 27 |c 05 |h 275-285 |